Missing person image small Matthieu Collin

Representative before the EPO

Missing person image thumb Missing person image thumb Missing person image thumb
Company dna inserm transfert ip department 7 rue watt
no operation time available
Inserm Transfert
Headquarter in Paris
Technology Transfer Office

We have observed 142 EP applications Matthieu Collin has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after January 14, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12729116

NKp46-MEDIATED NK CELL TUNING

IPC classification:
A61K 39/00, A61K 38/17
Applicant:
Université de la Méditerranée - Aix-Marseille II
Applicant:
Innate Pharma SA
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Lukas Völlmy, Innate Pharma SA
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ GRANT OF PATENT INTENDED
EP14721259

METHODS AND KITS FOR TESTING THE GENOTOXICITY OF AN AGENT

IPC classification:
G01N 33/50
Applicant:
Centre Hospitalier Universitaire de Rouen
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Rouen
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14718603

METHODS FOR STIMULATING ANTIGEN-SPECIFIC T CELL RESPONSES

IPC classification:
G01N 33/68, G01N 33/50
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14725123

FGF23 AS A BIOMARKER FOR PREDICTING THE RISK OF MORTALITY DUE TO END STAGE LIVER DISEASE

IPC classification:
G01N 33/74
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14726637

USE OF URINARY HIV NUCLEIC ACIDS TO DIAGNOSE AND MONITOR HIV-ASSOCIATED NEPHROPATHY (HIVAN)

IPC classification:
C12Q 1/70
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14728216

BIOMARKER OF REHOSPITALIZATION AFTER HEART FAILURE

IPC classification:
G01N 33/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Centre Hospitalier Universitaire de Toulouse
Agent:
Cabinet Plasseraud
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14730859

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ERYTHROPOIETIC PROTOPORPHYRIA

IPC classification:
A61P 17/00, A61P 7/00, A61K 31/7125, C12N 15/113
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14729335

ANTI-HER2 SINGLE DOMAIN ANTIBODIES, POLYPEPTIDES COMPRISING THEREOF AND THEIR USE FOR TREATING CANCER

IPC classification:
A61K 39/00, C07K 16/32
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14732529

RAC1 INHIBITORS FOR INDUCING BRONCHODILATION

IPC classification:
A61P 11/08, A61P 11/06, A61K 45/00, A61K 31/496
Applicant:
Centre Hospitalier Universitaire Nantes
Applicant:
Université de Nantes
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Lavoix
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ GRANT OF PATENT INTENDED
EP14731639

PHARMACEUTICAL COMPOSITIONS FOR PREVENTING GLUCOCORTICOID-INDUCED CORNEAL OR SKIN THINNING

IPC classification:
A61K 9/00, A61K 31/573, A61K 9/08, A61K 9/06, A61K 31/585, A61P 29/00, A61P 17/00, A61P 27/02
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14733199

METHODS FOR EXPRESSING A POLYNUCLEOTIDE OF INTEREST IN THE RETINA OF A SUBJECT

IPC classification:
C07K 14/47, C12N 7/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ GRANT OF PATENT INTENDED
EP14735525

INTERLEUKIN 15 (IL-15) ANTAGONISTS AND USES THEREOF FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES

IPC classification:
C12N 15/62, C12N 15/00, C07K 14/54, A61K 38/20
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université d'Angers
Applicant:
Université de Nantes
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14735542

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

IPC classification:
A61P 11/00, A61K 38/20
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Lille 1 Sciences et Technologies
Applicant:
Université de Droit et de la Santé de Lille 2
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ GRANT OF PATENT INTENDED
EP14735579

NOVEL ALTERNATIVE SPLICE TRANSCRIPTS FOR MHC CLASS I RELATED CHAIN ALPHA (MICA) AND USES THEREOF

IPC classification:
A61K 38/00, C12N 5/00, C07K 14/47
Applicant:
Université de Nantes
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14737236

METHODS FOR PERFORMING ANTISENSE OLIGONUCLEOTIDE-MEDIATED EXON SKIPPING IN THE RETINA OF A SUBJECT IN NEED THEREOF

IPC classification:
A61K 31/7088, C12N 15/113
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Lavoix
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14746985

ANTI-CLAUDIN 1 ANTIBODIES AND USES THEREOF

IPC classification:
A61P 35/00, A61K 39/395, C07K 16/18
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14741881

ANTI-CLAUDIN 1 ANTIBODIES FOR USE IN THE TREATMENT OF COLORECTAL CANCER

IPC classification:
C07K 16/28, A61P 35/00, A61K 39/395
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14744575

METHODS AND KITS FOR IDENTIFYING EFFECTOR TREG CELLS

IPC classification:
G01N 33/569
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ GRANT OF PATENT INTENDED
EP14755794

IMMUNOADJUVANT COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/39
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ GRANT OF PATENT INTENDED
EP14766928

METHODS FOR DETERMINING HUMAN SPERM QUALITY

IPC classification:
C12Q 1/48, G01N 33/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Centre Hospitalier Régional et Universitaire de Lille
Agent:
Valérie Schwalek, SCB S.A.S.
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ GRANT OF PATENT INTENDED
EP14766458

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS

IPC classification:
A61P 43/00, A61P 11/00, A61K 31/712, C12N 15/113
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14766481

METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF EPILEPSY

IPC classification:
A61P 25/08, A61K 31/513
Applicant:
Université de Bordeaux
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ GRANT OF PATENT INTENDED
EP14766503

LENTIVIRAL VECTORS HAVING A MUTATED INTEGRASE PROTEIN AND USES THEREOF

IPC classification:
C12N 15/86, C07K 14/005
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ GRANT OF PATENT INTENDED
EP14786873

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF POLYOMAVIRUS INFECTIONS

IPC classification:
A61P 35/00, A61P 13/12, A61P 31/20, A61K 31/7068
Applicant:
Ecole Normale Supérieure de Lyon
Applicant:
Les Hospices Civils de Lyon
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Claude Bernard Lyon I (UCBL)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP14793193

NEW ALZHEIMER'S DISEASE ANIMAL MODEL

IPC classification:
A01K 67/027, G01N 33/50, C07K 14/47, C12N 15/86, C12N 15/85
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14799415

A RHO GTPASE ACTIVATOR FOR USE AS ANTIMICROBIAL AGENT

IPC classification:
A61P 31/00, A61K 39/39, A61K 38/16
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre Hospitalier Universitaire de Nice
Applicant:
University of Nice (Université Nice Sophia Antipolis)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP13836207

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PANCREATIC CANCERS

IPC classification:
A61P 35/00, A61K 38/17
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP14808905

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIAS

IPC classification:
A61P 7/00, A61K 31/396
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP14806623

MAFB MUTANTS AND USES THEREOF

IPC classification:
C07K 14/82, C07K 14/47
Applicant:
Europäisches Laboratorium für Molekularbiologie (European Molecular Biology Laboratory (EMBL), Heidelberg)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP14809644

METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL REMODELING

IPC classification:
C12N 15/113, C07K 16/30, C07K 16/28, C07K 16/18
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Assistance Publique Hôpitaux de Marseille
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP14833136

METHODS FOR THE PREVENTION AND TREATMENT OF DIABETIC CARDIOMYOPATHY USING MIR-424/322

IPC classification:
C12N 15/864, A61K 48/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP14809410

METHODS FOR ADHERING TISSUE SURFACES AND MATERIALS AND BIOMEDICAL USES THEREOF

IPC classification:
A61K 33/00, A61K 31/695, A61K 9/70, A61K 47/02, A61K 45/06, A61K 38/48, A61L 26/00, A61L 24/00
Applicant:
Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Paris 13 University (Universite Paris 13 Nord)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP14824852

COMBINATION OF AN ARSENIC COMPOUND AND AT LEAST ONE RETINOID FOR TREATING ACUTE MYELOID LEUKEMIA

IPC classification:
A61P 35/02, A61K 33/36, A61K 31/285, A61K 31/203
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION IN PROGRESS
EP15700100

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR REDUCING METASTATIC DISSEMINATION

IPC classification:
G01N 33/50, A61P 35/04, A61K 31/164
Applicant:
Ecoles des Hautes en Sante Publique (EHESP)
Applicant:
Université de Rennes 1
Applicant:
Centre Hospitalier Universitaire de Toulouse
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Bourgogne Dijon
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
University of the French West Indies and Guiana (Université des Antilles et da la Guyane)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15703741

METHODS FOR THE PREVENTION AND THE TREATMENT OF EXTRACAPILLARY GLOMERULONEPHRITIS

IPC classification:
A61P 13/12, A61K 31/713, C12N 15/113
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15703742

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS

IPC classification:
A61K 31/4709, A61K 38/22, A61K 45/00, A61K 31/47, A61K 39/00, A61K 38/17
Applicant:
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15702743

SOLUBLE MONOMERIC ANTI-MULLERIAN HORMONE RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF

IPC classification:
C12N 15/62, C07K 14/71
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Cabinet Plasseraud
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15705274

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

IPC classification:
A61K 39/00, C07K 16/28, A61K 31/7032
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Université Lille 1 Sciences et Technologies
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15705594

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER

IPC classification:
C12N 15/62, C07K 14/47
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Cabinet Nony
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15704806

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES MEDIATED BY THE NRP-1/OBR COMPLEX SIGNALING PATHWAY

IPC classification:
G01N 33/50, G01N 33/574
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Applicant:
Université de Bourgogne Dijon
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15708510

CARBAPENEMASE AND ANTIBACTERIAL TREATMENT

IPC classification:
C12N 9/86
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15708545

METHODS AND KITS FOR CLASSIFYING DIFFUSE LARGE B-CELL LYMPHOMAS (DLBCLs) INTO GCB-DLBCLs OR INTO ABC-DLBCLs

IPC classification:
C12Q 1/68
Applicant:
Université de Rouen
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Cabinet Plasseraud
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15709213

DIAGNOSIS METHOD FOR LUPUS

IPC classification:
G01N 33/564
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15711162

TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS EPAC1 INHIBITORS FOR THE TREATMENT OF MYOCARDIAL INFARCTION INJURY

IPC classification:
A61P 9/10, A61K 31/47, A61K 45/06
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15710530

A METHOD FOR INDUCING HUMAN CHOLANGIOCYTE DIFFERENTIATION

IPC classification:
C12N 5/071
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15710188

METHODS FOR PREDICTING ACUTE REJECTION IN HEART RECIPIENTS

IPC classification:
C12Q 1/68
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15712159

NEW BIOMARKER FOR OUTCOME IN AML PATIENTS

IPC classification:
C12Q 1/68
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15713503

AN ISOLATED DONOR MHC-DERIVED PEPTIDE AND USES THEREOF

IPC classification:
C07K 14/435
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Nantes
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15713778

NEW METHOD FOR PRODUCING OUTER MEMBRANE VESICLES

IPC classification:
A61K 39/00, C12N 1/06
Applicant:
Centre Hospitalier Universitaire de Toulouse
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Recherche Agronomique (INRA)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15715289

ANTIBODIES RECOGNIZING THE CENTRAL DOMAIN OF DNA POLYMERASE POL THETA, AND USE THEREOF FOR DIAGNOSING CANCER

IPC classification:
C07K 16/40
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Agent:
Cabinet Regimbeau
Status:
█ EXAMINATION REQUESTED
EP15715758

POLYPEPTIDES AND USES THEREOF FOR REDUCING CD95-MEDIATED CELL MOTILITY

IPC classification:
C07K 14/435
Applicant:
University of Nottingham
Applicant:
University of the French West Indies and Guiana (Université des Antilles et da la Guyane)
Applicant:
Université de Bordeaux
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15716069

ANTIBODIES FOR THE PREVENTION OR THE TREATMENT OF BLEEDING EPISODES

IPC classification:
A61P 7/04, A61K 39/395, C07K 16/36
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Nicolas Marro, Cabinet Beau de Loménie (CBDL)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15718902

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VASO-OCCLUSIVE CRISIS

IPC classification:
A61P 7/00, A61K 38/46, A61K 38/43, A61K 38/17
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15724533

NEW BIOMARKER FOR AML

IPC classification:
C12Q 1/68
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15725258

NEW METHOD FOR TREATING MELANOMA

IPC classification:
C07K 16/24, C07K 16/28, C07K 16/30, A61P 35/00, A61K 39/395, A61K 38/17
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Centre Hospitalier Universitaire de Toulouse
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15723913

MIF INHIBITORS FOR THE ACUTE OR CHRONIC TREATMENT OF PULMONARY HYPERTENSION

IPC classification:
A61P 11/00, A61K 31/423
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Icosa
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15723721

ANTI- EGFR CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/28
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15726593

ANTI-NEUROTENSIN LONG FRAGMENT ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/30, A61K 39/00, A61P 35/00, C07K 16/18
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15729772

ANTI-NEUROTENSIN ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/395, A61K 33/24, C07K 16/26
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15728015

METHODS AND COMPOSITIONS FOR DIAGNOSING, MONITORING AND TREATING CANCER

IPC classification:
G01N 33/574
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Bourgogne Dijon
Agent:
Cabinet Plasseraud
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15731531

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES

IPC classification:
A61P 35/02, A61K 31/165
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15726633

PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES

IPC classification:
A61K 38/16, C07K 14/005
Applicant:
ICM - Institut du Cerveau et da la Moelle Epinière
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15728519

PHARMACEUTICAL COMPOSITIONS COMPRISING AN AT2R AGONIST FOR TREATING PAIN

IPC classification:
A61P 29/00, A61K 31/365
Applicant:
Université Lille 1 Sciences et Technologies
Applicant:
University of Nice (Université Nice Sophia Antipolis)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université d'Angers
Applicant:
Université de Nantes
Applicant:
Université de Droit et de la Santé de Lille 2
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15731937

FREE NUCLEIC ACIDS AND MIRNA AS NON-INVASIVE METHOD FOR DETERMINING EMBRYO QUALITY

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Centre Hospitalier Universitaire de Montpellier
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15731951

METHODS EMPLOYING CIRCULATING DNA AND MIRNA AS BIOMARKERS FOR FEMALE INFERTILITY

IPC classification:
C12Q 1/68
Applicant:
Centre Hospitalier Universitaire de Montpellier
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15734351

ANTI- MGLUR2 CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF

IPC classification:
A61P 25/00, A61K 39/395, C07K 16/28
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15734409

METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAIN

IPC classification:
A61K 31/713, C12N 15/113
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15735940

A NEW BIOMARKER OF CHRONIC ALLOGRAFT NEPHROPATHY AND OF RENAL TRANSPLANT REJECTION

IPC classification:
A61K 39/00, G01N 33/68
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15738908

AN ISOLATED INTERLEUKIN-34 POLYPEPTIDE FOR USE IN PREVENTING TRANSPLANT REJECTION AND TREATING AUTOIMMUNE DISEASES

IPC classification:
A61P 37/06, A61K 38/20
Applicant:
Université de Nantes
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15738898

METHODS FOR THE INTERCELLULAR TRANSFER OF ISOLATED MITOCHONDRIA IN RECIPIENT CELLS

IPC classification:
C12N 5/00, A61K 35/12
Applicant:
Centre Hospitalier Universitaire de Montpellier
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Hoffmann Eitle PartmbB
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15731560

PHARMACEUTICAL COMPOSITIONS COMPRISING AGONISTS OF OREXIN-1 RECEPTOR OX1R FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES

IPC classification:
A61K 47/56, A61P 1/04, A61K 38/22, A61K 38/17
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ EXAMINATION REQUESTED
EP15744591

AN ANTI-CD45RC ANTIBODY FOR USE AS DRUG

IPC classification:
A61P 37/06, C07K 16/28
Applicant:
Université de Nantes
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Examination is in progress
EP15760171

METHODS OF DIAGNOSING AND TREATING CANCER

IPC classification:
C12Q 1/68
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15780771

IMMUNOLOGICAL TREATMENT OF CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY

IPC classification:
A61K 39/00, C07K 16/28, A61K 39/395
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15766500

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS

IPC classification:
A61P 11/00, A61K 31/496, A61K 45/00, A61K 31/435
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15816218

METHODS FOR SCREENING A SUBJECT FOR A CANCER

IPC classification:
C12Q 1/68
Applicant:
Institut régional du Cancer Montpellier / Val d’Aurelle
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15794141

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/5513, A61K 31/435, A61P 35/00, A61K 31/47, A61K 45/06
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15790561

METHOD FOR IDENTIFYING IN A SUBJECT TUMOUR CELLS BEARING A T315I MUTATION

IPC classification:
C12Q 1/68
Applicant:
University of Poitiers (Université de Poitiers)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15797960

METHODS OF DIAGNOSING CANCER AND OF PREDICTING RESPONSE OF CANCER TO DENDROGENIN A TREATMENT

IPC classification:
C12Q 1/68
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15798429

USE OF OX1R ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES

IPC classification:
A61P 1/12, A61P 1/08, A61K 31/4545, A61K 31/00
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15798424

TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY ANTAGONISM OF THE IL-20R.

IPC classification:
A61K 39/00, C07K 16/28, C07K 16/24
Applicant:
Université Lille 1 Sciences et Technologies
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Droit et de la Santé de Lille 2
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15800811

POLYPEPTIDES FOR THE TREATMENT OF ANGIOGENESIS OR LYMPHANGIOGENESIS-RELATED DISEASES

IPC classification:
C12N 15/62, C07K 16/28, C07K 14/705, A61K 38/00
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15805233

HUMAN MONOCLONAL ANTIBODIES AGAINST AXL

IPC classification:
A61K 39/00, C07K 16/28, A61K 39/395
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Cabinet Plasseraud
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15808183

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTIONS

IPC classification:
A61K 31/7088, C12N 15/113
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Institut Pasteur - Transfert de technologie et entrepreneuriat
Applicant:
Institut Gustave Roussy
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15817338

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA

IPC classification:
A61P 31/04, A61K 38/16
Applicant:
Université Lille 1 Sciences et Technologies
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15817376

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

IPC classification:
A61K 38/16
Applicant:
Université Lille 1 Sciences et Technologies
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15817861

METABOLICALLY STABLE APELIN ANALOGS IN THE TREATMENT OF DISEASE MEDIATED BY THE APELIN RECEPTOR

IPC classification:
C07K 14/47, C07K 7/08
Applicant:
Université de Strasbourg
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP15817381

ALPHA-CELL RE-GENERATION COMBINED WITH CONVERSION TO BETA CELLS

IPC classification:
A61P 3/10, C12N 5/071, A61K 35/39, A61K 31/197, A61K 45/06, A61K 39/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16700156

MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF HAEMOPHILIA

IPC classification:
C07K 14/745, A61K 38/48, A61K 38/36, C12N 9/64
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16700152

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ISCHEMIC CONDITIONS

IPC classification:
A61K 45/06, A61K 38/49, A61K 38/16, A61K 38/18, A61P 9/10, A61K 38/17
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16700495

HUMAN MONOCLONAL ANTIBODIES AGAINST OREXIN RECEPTOR TYPE 1

IPC classification:
A61K 39/00, C07K 16/30, C07K 16/28
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut régional du Cancer Montpellier / Val d’Aurelle
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16700493

HUMAN MONOCLONAL ANTIBODIES AGAINST OREXIN RECEPTOR TYPE 1

IPC classification:
A61K 39/00, C07K 16/30, C07K 16/28
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut régional du Cancer Montpellier / Val d’Aurelle
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16700279

METHODS FOR THE DIAGNOSIS OF PANCREATIC CANCER

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre Hospitalier Universitaire de Toulouse
Applicant:
Université Paul Sabatier Toulouse III
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16702068

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF EBOLA VIRUS DISEASE

IPC classification:
A61P 31/14, A61K 31/4965
Applicant:
Université de Bordeaux
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16702550

ANTI-RHO GTPASE CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/12, C07K 16/18
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16704213

POLYPEPTIDES FOR ENGINEERING INTEGRASE CHIMERIC PROTEINS AND THEIR USE IN GENE THERAPY

IPC classification:
C07K 19/00, C12N 15/867, A61K 48/00, C12N 15/62, C12N 9/22
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16704599

METHODS FOR PREDICTING THE RESPONSIVENESS OF A PATIENT AFFECTED WITH MALIGNANT HEMATOLOGICAL DISEASE TO CHEMOTHERAPY TREATMENT AND METHODS OF TREATMENT OF SUCH DISEASE

IPC classification:
G01N 33/574, C12Q 1/68, A61K 38/18
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université de Nantes
Applicant:
Université d'Angers
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre Hospitalier Universitaire d'Angers
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16705179

OREXIN-B POLYPEPTIDES AND USES THEREOF

IPC classification:
A61K 38/17
Applicant:
Université Paris Diderot - Paris 7
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16705174

METHODS FOR ON DEMAND PRE-EXPOSURE PROPHYLACTIC TREATMENT OF HIV INFECTION

IPC classification:
A61P 31/18, A61K 31/675, A61K 31/513
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16707709

NEW METHOD FOR TREATING AND PROGNOSING CANCER

IPC classification:
G01N 33/574, A61K 38/00
Applicant:
Université de Nantes
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université d'Angers
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Cabinet Becker & Associés
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16707767

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HIV INFECTION

IPC classification:
A61P 31/18, A61K 31/7088, C12N 15/115
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université de Bordeaux
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16707151

FGFR3 ANTAGONISTS

IPC classification:
A61K 31/4245, C07D 413/04
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16709394

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FILOVIRUS INFECTIONS

IPC classification:
A61K 31/7105, C12N 15/115, C12N 15/113
Applicant:
Université de Bordeaux
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16709287

ANTIBODIES SPECIFIC TO GLYCOPROTEIN (GP) OF EBOLA VIRUS AND USES FOR THE TREATMENT AND DIAGNOSIS OF EBOLA VIRUS INFECTION

IPC classification:
C07K 16/10
Applicant:
Université Claude Bernard Lyon I (UCBL)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Ecole Normale Supérieure de Lyon
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16712805

METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF DIABETES

IPC classification:
A61P 3/10, A61K 38/17
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre Hospitalier Universitaire de Toulouse
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16712794

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF NEUROLOGICAL PHENOTYPE ASSOCIATED WITH FRIEDREICH ATAXIA

IPC classification:
C07K 14/47, C12N 15/86, A61K 48/00
Applicant:
Université de Strasbourg
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16723255

NEW BIOMARKER FOR OUTCOME IN AML

IPC classification:
C12Q 1/68
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16719272

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HAEMORRHAGIC DISEASES

IPC classification:
A61K 39/395
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16721701

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH17 MEDIATED DISEASES

IPC classification:
C07K 14/705, C07K 16/28
Applicant:
University of Nottingham
Applicant:
Université de Bordeaux
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16722837

CXCL10 AS PREDICTIVE BIOMARKER OF RENAL TRANSPLANT ACUTE REJECTION AND DIAGNOSTIC BIOMARKER OF ANTIBODY-MEDIATED REJECTION (ABMR)

IPC classification:
G01N 33/68
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16738073

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS IN PATIENTS SUFFERING FROM CIRRHOSIS

IPC classification:
A61P 31/04, A61K 45/06, A61K 31/4745
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16725810

TREATMENT OF RETINAL DETACHMENT

IPC classification:
A61P 27/02, A61K 47/48
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16725818

METHODS AND PHARMACEUTICAL COMPOSITION FOR MODULATION POLARIZATION AND ACTIVATION OF MACROPHAGES

IPC classification:
A61P 37/00, A61P 31/00, A61P 35/00, A61K 48/00, A61K 38/00, A61K 31/00
Applicant:
Institut Pasteur - Transfert de technologie et entrepreneuriat
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Institut Gustave Roussy
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Cabinet Regimbeau
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16723755

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING PERIPHERAL DEMYELINATING DISEASES

IPC classification:
A61K 38/17
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16727366

METHODS AND PHARMACEUTICAL COMPOSITIONS (NTSR1 INHIBITORS) FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS

IPC classification:
A61K 39/00, C07K 16/30, C07K 16/28
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16732516

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE

IPC classification:
C12N 15/864, A61K 48/00, A61K 38/00, A61P 25/28
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16732520

METHODS FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE AND TRAUMATIC BRAIN INJURIES

IPC classification:
C07K 14/47, C12N 15/864, A61K 48/00, A61P 25/28
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16736396

POLYPEPTIDES FOR THE DIAGNOSIS AND THE TREATMENT OF C3 NEF ASSOCIATED C3 GLOMERULOPATHY

IPC classification:
C07K 14/435
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16734597

METHODS AND KITS FOR DETECTING PROTEIN-PROTEIN INTERACTIONS

IPC classification:
G01N 33/68, G01N 33/542
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16736045

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CYSTIC FIBROSIS

IPC classification:
A61P 11/00, A61K 31/712, C12N 15/113
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16736134

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR EXPRESSING A POLYNUCLEOTIDE OF INTEREST IN THE PERIPHERAL NERVOUS SYSTEM OF A SUBJECT

IPC classification:
A61K 48/00, C12N 15/864
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16723779

HUMAN MONOCLONAL ANTIBODIES FRAGMENTS INHIBITING BOTH THE CATH-D CATALYTIC ACTIVITY AND ITS BINDING TO THE LRP1 RECEPTOR

IPC classification:
C07K 16/40, C07K 16/30
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16750386

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE BY MUCOSAL VACCINATION WITH FC-COUPLED ANTIGENS

IPC classification:
A61K 39/00
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16741632

SUBSTITUTED HYDROPHOBIC BENZENE SULFONAMIDE THIAZOLE COMPOUNDS FOR USE IN TREATING CANCER

IPC classification:
A61P 35/00, A61K 31/426, C07D 277/46
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
University of Nice (Université Nice Sophia Antipolis)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16744695

METHODS FOR PREDICTING THE SURVIVAL TIME AND TREATMENT RESPONSIVENESS OF A PATIENT SUFFERING FROM A SOLID CANCER

IPC classification:
C12Q 1/68
Applicant:
Université Francois Rabelais de Tours
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16739453

METHODS FOR THE PROGNOSIS AND TREATMENT OF ENDOMETRIAL CARCINOMA

IPC classification:
G01N 33/574, A61K 39/00, C12Q 1/68
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16745690

MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF HAEMOPHILIA

IPC classification:
A61K 38/36, C07K 14/745, C12N 9/64
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16757251

METHODS FOR PREDICTING THE SURVIVAL TIME OF PATIENTS SUFFERING FROM A LUNG CANCER

IPC classification:
G01N 33/574
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16762800

ANTIBODIES HAVING SPECIFICITY TO NECTIN-4 AND USES THEREOF

IPC classification:
C07K 16/28, A61K 39/395
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16769951

T CELL RECEPTORS (TCR) AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF DIABETES

IPC classification:
C12N 5/0783, C07K 16/28, C07K 14/725
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16769927

SPECIFIC INTERLEUKIN-15 (IL-15) ANTAGONIST POLYPEPTIDE AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY AND AUTO-IMMUNE DISEASES

IPC classification:
C12N 15/62, C07K 14/715, C07K 14/54
Applicant:
Université d'Angers
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Centre Hospitalier Universitaire Nantes
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16791529

ANTI-MULLERIAN HORMONE (AMH) NEUTRALIZING ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/26
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16775121

POLYPEPTIDES CAPABLE OF INHIBITING THE BINDING BETWEEN LEPTIN AND NEUROPILIN-1

IPC classification:
C07K 14/705, C07K 14/72, C07K 14/575
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université de Bourgogne Dijon
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16775184

BIOFUNCTIONALIZED NANOPARTICLES AND USES THEREOF IN ADOPTIVE CELL THERAPY

IPC classification:
A61K 39/12, A61K 39/39
Applicant:
Université Claude Bernard Lyon I (UCBL)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Ecole Normale Supérieure de Lyon
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16775236

METHODS FOR DETERMINING THE METABOLIC STATUS OF LYMPHOMAS

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16784461

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATORY DISEASES

IPC classification:
A61K 38/22, A61K 38/17
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16781760

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RETINAL CAPILLARY NON-PERFUSION

IPC classification:
A61P 9/10, A61K 31/551, A61K 31/4409, A61K 31/437
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16790279

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHOROIDAL NEOVASCULARISATION

IPC classification:
A61P 27/02, A61K 31/585, A61K 45/06
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16779107

AN AGENT CAPABLE OF DEPLETING CD8 T CELLS FOR THE TREATMENT OF MYOCARDIAL INFARCTION OR ACUTE MYOCARDIAL INFARCTION

IPC classification:
C07K 16/28, A61P 9/10, A61K 39/00
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16787439

ANTI-NRG1 (HEREGULIN) ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/00, C07K 16/32, C07K 16/28
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16797496

ANTI- NKG2D SINGLE DOMAIN ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/32, A61K 39/00, C07K 16/28, G01N 33/53, A61K 39/395, C07K 16/00
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made
EP16793890

METHODS FOR PREDICTING THE SURVIVAL TIME OF PATIENTS WITH DECOMPENSATED ALCOHOLIC CIRRHOSIS

IPC classification:
C12Q 1/68
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
█ Request for examination was made

Please Sign in to use this feature